Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report by E. A. Rezukhina, O. V. Rodnenkov, T. V. Martynyuk

Get full text

Patient and disease characteristics of pulmonary arterial hypertension patients for prostacyclin receptor agonist selexipag treatment initiation by E. A. Rezukhina, O. V. Rodnenkov, T. V. Martynyuk

Get full text

The clinical profile of pulmonary arterial hypertension in newly diagnosed patients with connective tissue disease from the point of view of the cardiologist by E. A. Rezukhina, M. A. Zubova, O. V. Rodnenkov, T. V. Martynyuk

Get full text

Possibility of evaluation of oxygen transport function in PAH patients on effective selexipag-based therapy by E. S. Allakhverdiev, E. A. Rezukhina, O. V. Slatinskaya, O. V. Rodnenkov, G. V. Maksimov, T. V. Martynyuk

Get full text

MANAGEMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE PANDEMIC OF A NEW CORONAVIRUS INFECTION by T. V. Martynyuk, A. M. Aleevskaya, O. V. Rodnenkov, A. V. Zorin, A. M. Kasparova, S. N. Nakonechnikov, I. E. Chazova

Get full text

Assessment of the effectiveness of PAH-specific therapy, including selexipag, in patients with idiopathic pulmonary hypertension according to a comprehensive examination using Rama... by E. S. Allakhverdiev, E. A. Rezukhina, O. V. Slatinskaya, O. V. Rodnenkov, Zh. V. Bochkova, N. A. Brazhe, G. V. Maksimov, T.  V. Martynyuk

Get full text